185 related articles for article (PubMed ID: 20385574)
1. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.
Molvaersmyr AK; Saether T; Gilfillan S; Lorenzo PI; Kvaløy H; Matre V; Gabrielsen OS
Nucleic Acids Res; 2010 Aug; 38(15):4970-84. PubMed ID: 20385574
[TBL] [Abstract][Full Text] [Related]
2. The chromatin remodeling factor Mi-2alpha acts as a novel co-activator for human c-Myb.
Saether T; Berge T; Ledsaak M; Matre V; Alm-Kristiansen AH; Dahle O; Aubry F; Gabrielsen OS
J Biol Chem; 2007 May; 282(19):13994-4005. PubMed ID: 17344210
[TBL] [Abstract][Full Text] [Related]
3. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
[TBL] [Abstract][Full Text] [Related]
4. The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation.
Fuglerud BM; Ledsaak M; Rogne M; Eskeland R; Gabrielsen OS
Epigenetics Chromatin; 2018 Jun; 11(1):35. PubMed ID: 29954426
[TBL] [Abstract][Full Text] [Related]
5. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
6. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.
Bies J; Markus J; Wolff L
J Biol Chem; 2002 Mar; 277(11):8999-9009. PubMed ID: 11779867
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.
Bengtsen M; Sørensen L; Aabel L; Ledsaak M; Matre V; Gabrielsen OS
Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):751-760. PubMed ID: 28495617
[TBL] [Abstract][Full Text] [Related]
8. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
[TBL] [Abstract][Full Text] [Related]
9. Stress-induced inactivation of the c-Myb transcription factor through conjugation of SUMO-2/3 proteins.
Sramko M; Markus J; Kabát J; Wolff L; Bies J
J Biol Chem; 2006 Dec; 281(52):40065-75. PubMed ID: 17077080
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain.
Miglarese MR; Richardson AF; Aziz N; Bender TP
J Biol Chem; 1996 Sep; 271(37):22697-705. PubMed ID: 8798443
[TBL] [Abstract][Full Text] [Related]
11. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
12. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation.
Sano Y; Ishii S
J Biol Chem; 2001 Feb; 276(5):3674-82. PubMed ID: 11073948
[TBL] [Abstract][Full Text] [Related]
13. Ovol1 represses its own transcription by competing with transcription activator c-Myb and by recruiting histone deacetylase activity.
Nair M; Bilanchone V; Ortt K; Sinha S; Dai X
Nucleic Acids Res; 2007; 35(5):1687-97. PubMed ID: 17311813
[TBL] [Abstract][Full Text] [Related]
14. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
15. P300 transcriptional repression is mediated by SUMO modification.
Girdwood D; Bumpass D; Vaughan OA; Thain A; Anderson LA; Snowden AW; Garcia-Wilson E; Perkins ND; Hay RT
Mol Cell; 2003 Apr; 11(4):1043-54. PubMed ID: 12718889
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
17. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
18. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.
Morita Y; Kanei-Ishii C; Nomura T; Ishii S
Mol Biol Cell; 2005 Nov; 16(11):5433-44. PubMed ID: 16162816
[TBL] [Abstract][Full Text] [Related]
19. Two regions in c-myb proto-oncogene product negatively regulating its DNA-binding activity.
Tanaka Y; Nomura T; Ishii S
FEBS Lett; 1997 Aug; 413(1):162-8. PubMed ID: 9287136
[TBL] [Abstract][Full Text] [Related]
20. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
Ladendorff NE; Wu S; Lipsick JS
Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
